NCT01934712View on ClinicalTrials.gov

A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 30, 2013

Primary Completion Date

January 28, 2014

Study Completion Date

January 28, 2014

Conditions
DiabetesDiabetes Mellitus, Type 1
Interventions
DRUG

Faster-acting insulin aspart

Single dose injected subcutaneously (s.c, under the skin)

DRUG

insulin aspart

Single dose injected subcutaneously (s.c, under the skin)

Trial Locations (1)

812-0025

Novo Nordisk Investigational Site, Fukuoka

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01934712 - A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 Diabetes | Biotech Hunter | Biotech Hunter